Published in Nature on November 05, 2009
High-quality draft assemblies of mammalian genomes from massively parallel sequence data. Proc Natl Acad Sci U S A (2010) 22.97
Genome analyses substantiate male mutation bias in many species. Bioessays (2011) 0.97
Bayesian molecular clock dating of species divergences in the genomics era. Nat Rev Genet (2015) 0.95
Cretaceous avian crops reveal dietary secrets and pose evolutionary questions. Proc Natl Acad Sci U S A (2011) 0.75
Ebola obstructs malaria control. Nature (2014) 2.50
Keeping genes out of terrorists' hands. Nature (2009) 1.70
Cancer complexity slows quest for cure. Nature (2008) 1.47
Should you edit your children's genes? Nature (2016) 1.46
Icelandic genomics firm goes bankrupt. Nature (2009) 1.44
Experimental treatments aim to prevent brain damage in babies. Nature (2016) 1.39
Human genome at ten: Life is complicated. Nature (2010) 1.24
Genome sequencing: the third generation. Nature (2009) 1.16
Sex bias blights drug studies. Nature (2010) 1.16
Cloud cover protects gene data. Nature (2015) 1.11
Proving Zika link to birth defects poses huge challenge. Nature (2016) 1.04
'Seek, test and treat' slows HIV. Nature (2010) 1.04
Mobile-phone health apps deliver data bounty. Nature (2016) 1.01
How to beat HIV. Nature (2015) 1.00
Zika highlights role of controversial fetal-tissue research. Nature (2016) 0.97
The automated lab. Nature (2014) 0.93
Anti-ageing pill pushed as bona fide drug. Nature (2015) 0.91
Pint-sized DNA sequencer impresses first users. Nature (2015) 0.90
Ebola failures prompt WHO rethink. Nature (2015) 0.90
Genomics shifts focus to rare diseases. Nature (2009) 0.88
Pet dogs set to test anti-ageing drug. Nature (2014) 0.88
'Killer application' for protein synthesis is retracted. Nature (2009) 0.88
A synthetic-biology reality check. Nature (2009) 0.86
Racial bias continues to haunt NIH grants. Nature (2015) 0.86
Rule rewrite aims to clean up scientific software. Nature (2015) 0.85
A radical revision of human genetics. Nature (2016) 0.84
Thousands of proteins affected by miRNAs. Nature (2008) 0.83
Promising gene therapies pose million-dollar conundrum. Nature (2016) 0.83
MSF takes bigger global-health role. Nature (2015) 0.79
The Ebola questions. Nature (2014) 0.79
World struggles to stop Ebola. Nature (2014) 0.79
French teenager healthy 12 years after ceasing HIV treatment. Nature (2015) 0.79
HIV: The next shot. Nature (2008) 0.78
How to get the most from a gene test. Nature (2008) 0.78
Scientists worry as cancer moonshots multiply. Nature (2016) 0.78
Ebola R&D woes spur action. Nature (2015) 0.77
Spectre of Ebola haunts Zika response. Nature (2016) 0.77
Synthetic biology called to order. Nature (2015) 0.76
Myriad Genetics embroiled in breast-cancer data fight - again. Nature (2016) 0.76
Infectious disease: Ebola's lost ward. Nature (2014) 0.76
Synthetic biology lures Silicon Valley investors. Nature (2015) 0.75
Rwanda feels the pinch as donors slash health aid. Nature (2016) 0.75
Researchers wrestle with a privacy problem. Nature (2015) 0.75
Darwin 200: The other strand. Nature (2009) 0.75
Ebola virus lingers longer than scientists thought. Nature (2016) 0.75
Gene variants linked to success at school prove divisive. Nature (2016) 0.75
Interventions might offer a pregnant pause in addiction. Nat Med (2008) 0.75
'Normal' genes key to cancer growth. Nature (2008) 0.75
Facebook couple commits $3 billion to cure disease. Nature (2016) 0.75
Proposed Ebola biobank would strengthen African science. Nature (2015) 0.75
Salary for CIRM head despite deficit. Nature (2008) 0.75
Young scientists ditch postdocs for biotech start-ups. Nature (2016) 0.75
Cybercrime fight targets user error. Nature (2015) 0.75
The rise and fall and rise again of 23andMe. Nature (2017) 0.75
How Ebola-vaccine success could reshape clinical-trial policy. Nature (2015) 0.75
Ebola outbreak in Africa ends - but gaps in public health leave region vulnerable. Nature (2017) 0.75
HIV trial attacked. Nature (2014) 0.75
So similar, yet so different. Nature (2007) 0.75
State cuts fuel California protests. Nature (2011) 0.75
Gene chips unmask cryptic diseases. Nature (2008) 0.75
Chief scientist quits California stem-cell agency. Nature (2009) 0.75
California stem-cell grants awarded. Nature (2009) 0.75
Budget woes sink marine archive. Nature (2011) 0.75
Gene-testing firms set sights on drug development. Nature (2015) 0.75
US AIDS chief lays out priorities. Nature (2009) 0.75
Scripps merger fiasco highlights US funding woes. Nature (2014) 0.75
Science group seeks to guide Silicon Valley philanthropists. Nature (2016) 0.75
Alzheimer's data lawsuit is sign of growing tensions. Nature (2015) 0.75
Giant gene banks take on disease. Nature (2014) 0.75